Platelet Count Measured Prior to Cancer Development Is a Risk Factor for Future Symptomatic Venous Thromboembolism: The Tromsø Study

Title
Platelet Count Measured Prior to Cancer Development Is a Risk Factor for Future Symptomatic Venous Thromboembolism: The Tromsø Study
Authors
Keywords
Platelets, Venous thromboembolism, White blood cells, Cancer detection and diagnosis, Thrombosis, Body mass index, Platelet activation, Cancer risk factors
Journal
PLoS One
Volume 9, Issue 3, Pages e92011
Publisher
Public Library of Science (PLoS)
Online
2014-03-19
DOI
10.1371/journal.pone.0092011

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now